Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Aliana Miron

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
American Journal of Therapeutics|October 7, 2025
Xanomeline/Trospium (Cobenfy): A Novel Approach for the Treatment of Schizophrenia in AdultsAna Aliana Miron, Petru Iulian Ifteni, Timothy Nguyen, et al.
American Journal of Therapeutics|June 24, 2022
Neutropenia in Patients With Clozapine-Treated Schizophrenia: An Effect of Clozapine or a Consequence of SARS-CoV-2 Infection? A Systematic ReviewSilvia Moga, Andreea Teodorescu, Ana Dragan, et al.
Psychiatry Research|June 19, 2026
Patterns of onset and progression of psychoses induced by psychoactive substance usePetru Ifteni, Ana Aliana Miron, Ruxandra Necula, et al.
The Psychiatric Quarterly|September 12, 2020
Clozapine for Treatment-Refractory Aggressive BehaviorTeodorescu Andreea, Ifteni Petru, Ana Aliana Miron, et al.
Medicina (Kaunas, Lithuania)|April 27, 2024
Brain Abnormalities in Schizophrenia: A Comparative Imagistic StudyPaula Simina Petric, Petru Ifteni, Ana Aliana Miron, et al.
Neuropsychiatric Disease and Treatment|May 13, 2022
Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 InfectionSilvia Moga, Andreea Teodorescu, Petru Ifteni, et al.
American Journal of Therapeutics|April 25, 2023
Outcome of COVID-19 mRNA Vaccination in Patients Treated With Clozapine WHO Previously Went Through SARS-COV-2 InfectionSilvia Moga, Paula Simina Petric, Ana Aliana Miron, et al.
Frontiers in Psychiatry|January 1, 2026
A review of functionality assessment scales in schizophreniaPetru Ifteni, Ana Aliana Miron, Paula Simina Petric, et al.
American Journal of Therapeutics|May 1, 2024
Cognitive Outcomes in Nonacute Patients With Schizophrenia Treated With Long-Acting Injectable Antipsychotics Versus Oral AntipsychoticsPaula Simina Petric, Andreea Teodorescu, Ana Aliana Miron, et al.
Risk Management and Healthcare Policy|February 19, 2021
Clozapine Efficacy in a Case of Severe Treatment-Resistant Postpartum PsychosisAndreea Teodorescu, Petru Ifteni, Ana Dragan, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Journal of Therapeutics|October 7, 2025
Xanomeline/Trospium (Cobenfy): A Novel Approach for the Treatment of Schizophrenia in AdultsAna Aliana Miron, Petru Iulian Ifteni, Timothy Nguyen, et al.
American Journal of Therapeutics|June 24, 2022
Neutropenia in Patients With Clozapine-Treated Schizophrenia: An Effect of Clozapine or a Consequence of SARS-CoV-2 Infection? A Systematic ReviewSilvia Moga, Andreea Teodorescu, Ana Dragan, et al.
Psychiatry Research|June 19, 2026
Patterns of onset and progression of psychoses induced by psychoactive substance usePetru Ifteni, Ana Aliana Miron, Ruxandra Necula, et al.
The Psychiatric Quarterly|September 12, 2020
Clozapine for Treatment-Refractory Aggressive BehaviorTeodorescu Andreea, Ifteni Petru, Ana Aliana Miron, et al.
Medicina (Kaunas, Lithuania)|April 27, 2024
Brain Abnormalities in Schizophrenia: A Comparative Imagistic StudyPaula Simina Petric, Petru Ifteni, Ana Aliana Miron, et al.
Neuropsychiatric Disease and Treatment|May 13, 2022
Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 InfectionSilvia Moga, Andreea Teodorescu, Petru Ifteni, et al.
American Journal of Therapeutics|April 25, 2023
Outcome of COVID-19 mRNA Vaccination in Patients Treated With Clozapine WHO Previously Went Through SARS-COV-2 InfectionSilvia Moga, Paula Simina Petric, Ana Aliana Miron, et al.
Frontiers in Psychiatry|January 1, 2026
A review of functionality assessment scales in schizophreniaPetru Ifteni, Ana Aliana Miron, Paula Simina Petric, et al.
American Journal of Therapeutics|May 1, 2024
Cognitive Outcomes in Nonacute Patients With Schizophrenia Treated With Long-Acting Injectable Antipsychotics Versus Oral AntipsychoticsPaula Simina Petric, Andreea Teodorescu, Ana Aliana Miron, et al.
Risk Management and Healthcare Policy|February 19, 2021
Clozapine Efficacy in a Case of Severe Treatment-Resistant Postpartum PsychosisAndreea Teodorescu, Petru Ifteni, Ana Dragan, et al.
Pageof 2